Effective immunoprophylaxis with basiliximab plus triple therapy in renal transplantation: five-year single-center experience.

Abstract

We studied prospectively the efficacy and safety of basiliximab combined with triple immunosuppression in adult recipients of > or = 1 HLA-mismatched deceased donor renal grafts. All studied patients received equal immunosuppressive drugs: 20 mg infusion of basiliximab on day 0 and on day 4, cyclosporine microemulsion (Neoral), mycophenolate mofetil, and… (More)

Topics

Cite this paper

@article{Kandus2006EffectiveIW, title={Effective immunoprophylaxis with basiliximab plus triple therapy in renal transplantation: five-year single-center experience.}, author={Aljo{\vs}a Kandus and Kathleen Fernandes Grego and Miha Arnol and D. Kovac and Jelka Lindi{\vc} and Jadranka Buturovi{\'c} and Rafael Ponikvar and A. F. Bren}, journal={Transplantation proceedings}, year={2006}, volume={38 9}, pages={2853-5} }